Wilson Sonsini Goodrich & Rosati advised SR One, Norwest Venture Partners, and Delos Capital on the transaction.Zenas BioPharma, a clinical-stage global biopharmaceutical company, announced an upsized…
Zenas BioPharma’s Upsized $200 Million Series C Financing Round
![](https://globallegalchronicle.com/wp-content/uploads/2024/05/zenas-biopharmas-upsized-200-million-series-c-financing-round_6641c71625386.jpeg)